CHRD(CHRD)
CHRD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6.40B | $5.60B | $5.82B | $5.67B | $5.63B |
| Low | $6.17B | $5.53B | $4.60B | $4.91B | $4.88B |
| High | $6.58B | $5.73B | $7.01B | $6.47B | $6.42B |
| EBITDA Avg | $2.60B | $2.28B | $2.37B | $2.31B | $2.29B |
| Low | $2.51B | $2.25B | $1.87B | $2.00B | $1.98B |
| High | $2.67B | $2.33B | $2.85B | $2.63B | $2.61B |
| EBIT Avg | $1.49B | $1.31B | $1.36B | $1.32B | $1.31B |
| Low | $1.44B | $1.29B | $1.07B | $1.15B | $1.14B |
| High | $1.53B | $1.34B | $1.63B | $1.51B | $1.50B |
| Net Income Avg | $1.06B | $772M | $770M | $725M | $678M |
| Low | $992M | $622M | $496M | $599M | $560M |
| High | $1.29B | $1.04B | $1.02B | $857M | $802M |
| EPS Avg | $19.30 | $13.50 | $14.73 | $12.53 | $11.72 |
| Low | $17.16 | $10.75 | $8.58 | $10.35 | $9.69 |
| High | $22.35 | $17.96 | $17.67 | $14.82 | $13.87 |
| Analysts (Rev / EPS) | 5 / 7 | 5 / 8 | 6 / 6 | 4 / 3 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.48B | $1.44B | $1.35B | $1.35B | $1.36B | $1.37B | $1.37B | $1.35B |
| Low | $1.41B | $1.41B | $1.14B | $1.15B | $1.15B | $1.16B | $1.16B | $1.14B |
| High | $1.55B | $1.52B | $1.58B | $1.59B | $1.59B | $1.60B | $1.60B | $1.58B |
| EBITDA Avg | $603M | $587M | $549M | $550M | $553M | $556M | $556M | $548M |
| Low | $573M | $571M | $465M | $466M | $468M | $470M | $471M | $464M |
| High | $628M | $617M | $644M | $645M | $648M | $652M | $653M | $642M |
| EBIT Avg | $346M | $336M | $315M | $315M | $317M | $319M | $319M | $314M |
| Low | $329M | $328M | $267M | $267M | $268M | $270M | $270M | $266M |
| High | $360M | $354M | $369M | $370M | $372M | $374M | $374M | $368M |
| Net Income Avg | $239M | $218M | $194M | $184M | $187M | $196M | $211M | $204M |
| Low | $186M | $175M | $155M | $148M | $150M | $157M | $169M | $163M |
| High | $285M | $279M | $237M | $226M | $229M | $241M | $259M | $250M |
| EPS Avg | $4.22 | $3.86 | $3.42 | $3.26 | $3.30 | $3.47 | $3.73 | $3.61 |
| Low | $3.28 | $3.09 | $2.74 | $2.61 | $2.64 | $2.78 | $2.99 | $2.89 |
| High | $5.04 | $4.92 | $4.19 | $3.99 | $4.04 | $4.25 | $4.57 | $4.42 |
| Analysts (Rev / EPS) | 4 / 8 | 4 / 7 | 2 / 2 | 2 / 2 | 2 / 2 | 2 / 5 | 1 / 6 | 1 / 5 |